Established in 2015, Seqirus manufactures and performs research on influenza vaccines. This company conducts research using both egg-based and cell-based technologies. Seqirus is headquartered in Maidenhead, United Kingdom.
| Website | http://www.seqirus.com |
| Revenue | $61.3 million |
| Employees | View employees |
| Address | 29 Point L 3, Maidenhead, Berkshire SL6 8AA, GB |
| Fax | +44 800 360 1011 |
| Industry | Pharmaceuticals, Healthcare |
| Web Rank | 2 Million |
| Keywords | Seqirus, Sequiris, Csl Liverpool, Seqirus Inc. Careers Jobs, Seqirus Inc. |
| Competitors | Johnson & Johnson, Novartis, Merck & Co., Inc., Pfizer, GSK, AstraZeneca, Bristol Myers Squibb, Moderna Therapeutics, BioMarin Pharmaceutical Inc., Sanofi Pasteur +44 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Seqirus Inc employee's phone or email?
Seqirus Inc Questions
The Seqirus Inc annual revenue was $61.3 million in 2026.
Seqirus Inc is based in Maidenhead, Berkshire.
The NAICS codes for Seqirus Inc are [32541, 325414, 325, 3254, 32].
The SIC codes for Seqirus Inc are [283, 28].
G2Crowd Trusted
300K+
Plugin Users
